Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease

Background. Cystic fibrosis (CF) is a genetic disease that results in chronic infections of the lungs. CF patients experience intermittent pulmonary exacerbations (CFPE) that are associated with poor clinical outcomes. CFPE involves an increase in disease symptoms requiring more aggressive therapy....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Robert A. Quinn, Yan Wei Lim, Tytus D. Mak, Katrine Whiteson, Mike Furlan, Douglas Conrad, Forest Rohwer, Pieter Dorrestein
Natura: Artigo
Lingua:Inglês
Pubblicazione: PeerJ Inc. 2016-08-01
Serie:PeerJ
Soggetti:
Personalized medicine
Cystic fibrosis
Metabolomics
Exacerbation
Mass spectrometry
Accesso online:https://peerj.com/articles/2174.pdf
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi